SUTIMLIMAB – BIOVERATIV
Also known as BIVV-009 or TNT-009A
A monoclonal antibody.
Note: Monoclonal Antibodies are immune antibodies that are made identical to the parent cell, through a cloning process. Used to attach to a single target on cells (mono) at a cellular level, to target and perform a specific function on those cells. To help purify or make the target cells normal.
Phase III trials (2019) are finding Sutimlimab effective in the treatment of Cold Agglutinin Disease.
For the latest and up to date details find their official website.
Also see: SUTIMLIMAB-JOME a.k.a ENJAYMO (Pharmaceutical Treatment)